Imax (IMAX) analyst forecast and price target
Analyst forecast
Consensus of 14 analyst ratings
Based on 11 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wedbush | Maintained | Outperform | $60.00 from $54.00 | Oct 14, 2026 |
| Rosenblatt | Maintained | Buy | $65.00 | Oct 14, 2026 |
| B. Riley Securities | Maintained | Buy | $64.00 from $61.00 | Oct 8, 2026 |
| StoneX | Maintained | Buy | $65.00 from $60.00 | Oct 7, 2026 |
| Morgan Stanley | Initiated Coverage | Overweight | $63.00 | Sep 24, 2026 |
| Rosenblatt | Maintained | Buy | $65.00 from $60.00 | Sep 9, 2026 |
| Goldman Sachs | Maintained | Neutral | $50.00 from $42.00 | Sep 4, 2026 |
| Roth Capital | Maintained | Buy | $60.00 from $50.00 | Sep 3, 2026 |
| Macquarie | Maintained | Outperform | $55.00 from $50.00 | Sep 2, 2026 |
| B. Riley Securities | Maintained | Buy | $61.00 from $52.00 | Aug 24, 2026 |
| Rosenblatt | Maintained | Buy | $60.00 | Aug 19, 2026 |
| Rosenblatt | Maintained | Buy | $60.00 from $50.00 | Aug 10, 2026 |
| Wedbush | Maintained | Outperform | $54.00 from $46.00 | Jul 24, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $45.00 from $41.00 | Jul 24, 2026 |
| Rosenblatt | Maintained | Buy | $50.00 from $47.00 | Jul 24, 2026 |
| B. Riley Securities | Maintained | Buy | $52.00 from $48.00 | Jul 24, 2026 |
| JP Morgan | Maintained | Overweight | $50.00 from $47.00 | Jul 24, 2026 |
| Roth Capital | Maintained | Buy | $50.00 from $48.00 | Jul 24, 2026 |
| Barrington Research | Maintained | Outperform | $50.00 from $46.00 | Jul 24, 2026 |
| Rosenblatt | Maintained | Buy | $47.00 | Jul 20, 2026 |
Frequently asked questions
What is the price target for IMAX stock?
The average 12-month analyst price target for Imax (IMAX) is $57.00, with a high estimate of $65.00 and a low of $45.00, across 11 analysts.
Is IMAX a buy, sell, or hold?
Analysts covering Imax currently average a Buy rating: 12 buy, 2 hold and 0 sell, from 14 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for IMAX?
The average price target of $57.00 implies 10.27% upside from the last price of $51.69.
What is the latest analyst rating on IMAX?
On Oct 14, 2026, Wedbush maintained Imax at Outperform with a price target of $60.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.